Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19
Clinical trial NCT04381884 · COMPLETED
Trial details
- NCT number
- NCT04381884
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-18
- Primary completion
- 2020-09-29
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.